Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005

被引：4

作者：

Papa, Patrick ^{[1
]}

Whitefield, Brandon ^{[1
]}

Mortensen, Deborah S. ^{[1
]}

Cashion, Dan ^{[1
]}

Huang, Dehua ^{[1
]}

Torres, Eduardo ^{[1
]}

Parnes, Jason ^{[1
]}

Sapienza, John ^{[1
]}

Hansen, Joshua ^{[1
]}

Correa, Matthew ^{[1
]}

Delgado, Mercedes ^{[1
]}

Harris, Roy ^{[1
]}

Hegde, Sayee ^{[1
]}

Norris, Stephen ^{[1
]}

Bahmanyar, Sogole ^{[1
]}

Plantevin-Krenitsky, Veronique ^{[1
]}

Liu, Zheng ^{[1
]}

Leftheris, Katerina ^{[1
]}

Kulkarni, Ashutosh ^{[1
]}

Bennett, Brydon ^{[1
]}

Hur, Eun Mi ^{[2
]}

Ringheim, Garth ^{[2
]}

Khambatta, Godrej ^{[1
]}

Chan, Henry ^{[1
]}

Muir, Jeffrey ^{[1
]}

Blease, Kate ^{[1
]}

Burnett, Kelven ^{[1
]}

LeBrun, Laurie ^{[1
]}

Morrison, Lisa ^{[1
]}

Celeridad, Maria ^{[1
]}

Khattri, Roli ^{[1
]}

Cathers, Brian E. ^{[1
]}

机构：

[1] Bristol Myers Squibb, San Diego, CA 92121 USA

[2] Bristol Myers Squibb, Summit, NJ 07901 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2021年 / 64卷 / 16期

关键词：

KAPPA-B ACTIVATION; PKC-THETA; OPTIMIZATION; AUTOIMMUNITY; AEB071; CELLS; MICE;

D O I：

10.1021/acs.jmedchem.1c00388

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The PKC-theta isoform of protein kinase C is selectively expressed in T lymphocytes and plays an important role in the T cell antigen receptor (TCR)-triggered activation of mature T cells, T cell proliferation, and the subsequent release of cytokines such as interleukin-2 (IL-2). Herein, we report the synthesis and structure-activity relationship (SAR) of a novel series of PKC-theta inhibitors. Through a combination of structure-guided design and exploratory SAR, suitable replacements for the basic C4 amine of the original lead (3) were identified. Property-guided design enabled the identification of appropriately substituted C2 groups to afford potent analogs with metabolic stability and permeability to support in vivo testing. With exquisite general kinase selectivity, cellular inhibition of T cell activation as assessed by IL-2 expression, a favorable safety profile, and demonstrated in vivo efficacy in models of acute and chronic T cell activation with oral dosing, CC-90005 (57) was selected for clinical development.

引用

页码：11886 / 11903

页数：18

共 50 条

[21] Discovery of a selective inhibitor of doublecortin like kinase 1
Ferguson, Fleur M.
Nabet, Behnam
Raghavan, Srivatsan
Liu, Yan
Leggett, Alan L.
Kuljanin, Miljan
Kalekar, Radha L.
Yang, Annan
He, Shuning
Wang, Jinhua
Ng, Raymond W. S.
Sulahian, Rita
Li, Lianbo
Poulin, Emily J.
Huang, Ling
Koren, Jost
Dieguez-Martinez, Nora
Espinosa, Sergio
Zeng, Zhiyang
Corona, Cesear R.
Vastall, James D.
Ohi, Ryoma
Sim, Taebo
Kim, Nam Doo
Harshbarger, Wayne
Lizcano, Jose M.
Robers, Matthew B.
Muthaswamy, Senthil
Lin, Charles Y.
Look, A. Thomas
Haigis, Kevin M.
Mancias, Joseph D.
Wolpin, Brian M.
Aguirre, Andrew J.
Hahn, William C.
Westover, Kenneth D.
Gray, Nathanael S.
NATURE CHEMICAL BIOLOGY, 2020, 16 (06) : 635 - +
[22] The role of protein kinase D in neurotensin secretion mediated by protein kinase C-α/-δ and Rho/Rho kinase
Li, J
O'Connor, KL
Hellmich, MR
Greeley, GH
Townsend, CM
Evers, BM
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (27) : 28466 - 28474
[23] Selective modulation of protein kinase C-Θ during T-cell activation
Colin R. F. Monks
Hannah Kupfer
Idan Tamir
Avlin Barlow
Abraham Kupfer
Nature, 1997, 385 : 83 - 86
[24] Selective ceramide binding to protein kinase C-α and -δ isoenzymes in renal mesangial cells
Huwiler, A
Fabbro, D
Pfeilschifter, J
BIOCHEMISTRY, 1998, 37 (41) : 14556 - 14562
[25] Indolyl-naphthyl-maleimides as potent and selective inhibitors of protein kinase C-α/β
van Eis, Maurice J.
Evenou, JeanPierre
Schuler, Walter
Zenke, Gerhard
Vangrevelinghe, Eric
Wagner, Juergen
von Matt, Peter
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (04) : 781 - 786
[26] Regulation of tyrosinase activity by protein kinase C-β.
Wu, H
Park, HY
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 332A - 332A
[27] Selection of DNA ligands for protein kinase C-δ
Mallikaratchy, Prabodhika
Stahelin, Robert V.
Cao, Zehui
Cho, Wonhwa
Tan, Weihong
CHEMICAL COMMUNICATIONS, 2006, (30) : 3229 - 3231
[28] Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase
Mortensen, Deborah S.
Sapienza, John
Lee, Branden G. S.
Perrin-Ninkovic, Sophie M.
Harris, Roy
Shevlin, Graziella
Parnes, Jason S.
Whitefield, Brandon
Hickman, Matt
Khambatta, Gody
Bisonette, Rene R.
Peng, Sophie
Gamez, Jim C.
Leisten, Jim
Narla, Rama Krishna
Fultz, Kimberly E.
Sankar, Sabita
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (06) : 1588 - 1591
[29] Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase
Adams, Nicholas D.
Adams, Jerry L.
Burgess, Joelle L.
Chaudhari, Amita M.
Copeland, Robert A.
Donatelli, Carla A.
Drewry, David H.
Fisher, Kelly E.
Hamajima, Toshihiro
Hardwicke, Mary Ann
Huffman, William F.
Koretke-Brown, Kristin K.
Lai, Zhihong V.
McDonald, Octerloney B.
Nakamura, Hiroko
Newlander, Ken A.
Oleykowski, Catherine A.
Parrish, Cynthia A.
Patrick, Denis R.
Plant, Ramona
Sarpong, Martha A.
Sasaki, Kosuke
Schmidt, Stanley J.
Silva, Domingos J.
Sutton, David
Tang, Jun
Thompson, Christine S.
Tummino, Peter J.
Wang, Jamin C.
Xiang, Hong
Yang, Jingsong
Dhanak, Dashyant
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (10) : 3973 - 4001
[30] Terminal differentiation of epithelial cells in middle ear cholesteatoma:: Investigation of patterns of expression of protein kinase C-δ and protein kinase C-η
Miyazaki, H
Kojima, H
Tanaka, Y
Shiwa, M
Koga, T
Moriyama, H
LARYNGOSCOPE, 1999, 109 (11): : 1785 - 1792

← 1 2 3 4 5 →